Earli was featured in the White House Cancer Moonshot Fact Sheet today, as one of several key initiatives designed to get the U.S. closer to the Moonshot goal of reducing cancer deaths by 50%.

WIRED Feature – how Earli forces cancer to draw a “map” to itself:  A Proactive Way to Detect Cancer at Its Earliest Stages

Entrepreneur - The Heartbreaking Loss of a Child to Cancer Brought These 3 Founders Together.

Fast Company feature story – the fundamental change Earli may bring to patients: A cancer genius died from cancer. His startup is getting revenge.

Genetic Engineering & Biotechnology News - how Earli built a world-class team to solve one of the most difficult science problems: “Synthetic” Biomarkers Light Up Hidden Malignant Cancers.

Drug Discovery Trends - Earli's newest partnership. Earli and Accenture partner in quest to turn cancer against itself

Medical Newspaper (South Korea) - A new frontier in cancer treatment: controlling cancer cells and making them self-destruct (in Korean Language)

Newsweek Opinion – why early detection misses the mark without Early Treatment:  One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths.

CGT Live - Using DNA Nanoplasmids as a Diagnostic Tool in Cancer

Tech Target - Using a synthetic targeting platform that forces cancer cells to express synthetic biomarkers, Earli Inc. is developing strategies for early cancer detection.

Pharmaceutical Technology - Accenture Invests in Earli's Cancer Detection Tech.

Sydney Morning Herald - Earli’s human trial: Australia’s ‘high quality’ clinical trials lure Silicon Valley cancer fighting company.

World Economic Forum selects Earli - 100 firms worldwide to join its Global Innovator community.

Fast Company - Earli the only early cancer detection firm in list of 2021 World Changing Ideas.

The Atlantic - describes Sam Gambhir's quest to localize cancer early, and the vision for the future.

Tough Tech Today - Co-founder Cyriac Roeding tells the story of Earli in a video podcast.

German BusinessWeek (Wirtschaftswoche) - tells the story and breakthrough potential of Earli (in German language).

Forbes - This Company Raised $40 Million To Make Tumors Reveal Themselves.

Business Wire - Earli raises $40M in Series A funding led by Khosla Ventures, with Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital, two years after its $19.5M Seed round led by Andreessen Horowitz’s Bio Fund.

Stat News - Sam Gambhir described how new ways to detect cancer early will help pave the way for precision health.